Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Keith_Blundy
|
| gptkbp:developedBy |
therapeutics targeting RNA methyltransferases
|
| gptkbp:focusesOn |
RNA epigenetics
RNA-modifying enzymes |
| gptkbp:foundedIn |
2015
|
| gptkbp:founder |
gptkb:Eric_Miska
gptkb:Tony_Kouzarides |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:IP_Group
gptkb:Pfizer_Ventures gptkb:SR_One gptkb:UCL_Technology_Fund gptkb:Cambridge_Innovation_Capital |
| gptkbp:notableContributor |
oncology
cancer therapeutics |
| gptkbp:website |
https://www.stormtherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Cambridge_Innovation_Capital
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Storm Therapeutics
|